VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
VKTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
VKTXViking Therapeutics, Inc.
$26.84$3.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksVKTXQuarterly Balance Sheet

Viking Therapeutics, Inc. (VKTX) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Viking Therapeutics, Inc. (VKTX) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

VKTX Balance Sheet

Quarterly statement

VKTX Balance Sheet

Viking Therapeutics, Inc. (VKTX) balance sheet — 14-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets973M517.56M608.21M715.6M738.7M827.02M866.02M907.22M936.65M945.72M966.34M367.23M381.3M399.37M149.47M167.04M165.15M179.86M193.3M210.53M
Cash & Short-Term Investments959.81M501.66M602.96M705.74M714.57M807.72M851.86M902.61M930.44M942.26M962.98M362.08M376.24M392.92M135.66M155.49M155.02M168.92M184.9M202.1M
Cash Only677.61M125.75M118.12M165.81M100.38M33.88M37.94M26.68M50.35M43.91M195.58M55.52M37.19M69.52M18.36M36.63M29.41M16.23M12.45M26.37M
Short-Term Investments282.2M375.91M484.85M539.93M614.19M773.84M813.92M875.94M880.09M898.35M767.4M306.56M339.06M323.4M117.3M118.85M125.61M152.69M172.44M175.73M
Accounts Receivable00000000000000000000
Days Sales Outstanding--------------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets3.18M941K1.22M1.81M2.24M2.81M13.3M1.13M1.73M3.32M2.72M2.52M4.39M5.49M3.93M8.14M9.17M9.86M8.01M7.81M
Total Non-Current Assets4.17M4.33M33K131K712K834K970K1.1M1.24M1.11M1.18M1.26M1.36M1.32M1.43M1.49M1.54M1.65M1.73M134K
Property, Plant & Equipment3.85M4.01M085K666K780K892K1M1.11M977K1.05M1.13M1.2M1.27M1.35M1.42M1.49M1.56M1.63M25K
Fixed Asset Turnover--------------------
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments00000000000000000000
Other Non-Current Assets315K324K33K46K46K54K78K102K126K138K131K139K163K49K81K71K48K85K97K109K
Total Assets977.17M521.9M608.24M715.73M739.41M827.85M866.99M908.32M937.89M946.84M967.52M368.49M382.66M400.69M150.9M168.53M166.68M181.51M195.03M210.66M
Asset Turnover--------------------
Asset Growth %32.15%-36.96%-29.84%-21.2%-21.16%-12.57%-10.39%146.5%145.09%136.3%541.19%118.65%129.58%120.76%-22.63%-20%-25.75%-23.69%-22.03%-17.87%
Total Current Liabilities133.9M109.66M106.33M76.67M26.07M31.98M19.57M27.41M25.68M25.09M32.77M19.14M13.4M13.48M15.65M21.95M14.06M14.86M11.27M8.78M
Accounts Payable82.13M69.01M67.18M53.25M4.41M5.49M7.7M9.81M254K11.09M5.22M7.51M5.71M5.61M3.8M8.53M3.14M6.1M3.12M1.44M
Days Payables Outstanding---28.22K4K---------------
Short-Term Debt00000000480K00000000000
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities0000000024.95M00000000000
Current Ratio7.27x4.72x5.72x9.33x28.34x25.86x44.25x33.09x36.47x37.69x29.48x19.19x28.44x29.63x9.55x7.61x11.74x12.10x17.15x23.98x
Quick Ratio7.27x4.72x5.72x9.33x28.34x25.86x44.25x33.09x36.47x37.69x29.48x19.19x28.44x29.63x9.55x7.61x11.74x12.10x17.15x23.98x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities254.67M3.92M00318K410K502K630K755K766K852K936K1.02M1.1M1.18M1.26M1.34M1.41M1.49M0
Long-Term Debt250.66M0000000000000000000
Capital Lease Obligations4.01M3.92M00318K410K502K630K755K766K852K936K1.02M1.1M1.18M1.26M1.34M1.41M1.49M0
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities00000000000000000000
Total Liabilities388.57M113.58M106.33M76.67M26.39M32.39M20.07M28.04M26.44M25.86M33.63M20.07M14.42M14.58M16.83M23.21M15.4M16.28M12.76M8.78M
Total Debt254.69M4.09M0137K755K878K1M1.12M1.24M1.1M1.18M1.26M1.34M1.41M1.49M1.56M1.64M1.65M1.64M29K
Net Debt-422.92M-121.66M-118.12M-165.67M-99.62M-33M-36.94M-25.56M-49.11M-42.81M-194.4M-54.26M-35.85M-68.11M-16.87M-35.07M-27.77M-14.57M-10.81M-26.34M
Debt / Equity0.43x0.01x-0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.01x0.01x0.01x0.01x0.01x0.00x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage-2080.66x----11347.38x-2730.71x-1900.21x-1474.71x-1038.17x-1235.11x-976.00x-945.35x-11266.00x-599.78x-696.54x-2443.88x-583.19x-1451.67x--1028.67x
Total Equity588.6M408.32M501.92M639.06M713.03M795.46M846.92M880.28M911.45M920.98M933.89M348.42M368.24M386.12M134.06M145.32M151.28M165.23M182.27M201.88M
Equity Growth %-17.45%-48.67%-40.74%-27.4%-21.77%-13.63%-9.31%152.65%147.51%138.52%596.6%139.76%143.41%133.68%-26.45%-28.02%-29.01%-26.56%-23.17%-17.38%
Book Value per Share4.993.524.345.616.357.097.567.918.228.349.033.483.693.901.711.901.982.152.352.63
Total Shareholders' Equity588.6M408.32M501.92M639.06M713.03M795.46M846.92M880.28M911.45M920.98M933.89M348.42M368.24M386.12M134.06M145.32M151.28M165.23M182.27M201.88M
Common Stock1K1K1K1K1K1K1K1K1K1K1K1K1K1K1K1K1K1K1K1K
Retained Earnings-1.32B-1.13B-1.01B-847.55M-689.88M-599.1M-533.54M-487.91M-452.49M-427.55M-405.3M-377.94M-353.34M-330.81M-311.58M-292.05M-272.49M-256.72M-239.28M-223.18M
Treasury Stock00000000000-6.79M-6.79M-6.79M-6.79M-6.79M-6.79M-6.79M-5.12M0
Accumulated OCI-1.7M-1.15M-856K378K374K-166K-216K-788K1.63M-2.27M-1.6M-389K-905K-1.04M-618K-1.1M-1.76M-1.65M-1.41M-549K
Minority Interest00000000000000000000